BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
(Reuters) — Express Scripts Holding Co. sees Amazon.com Inc., which has been reported to be interested in entering the pharmacy market, as a possible partner rather than a competitor, the chief executive of the pharmacy benefit manager said Thursday on CNBC.
Express Scripts, the biggest PBM in the United States, and drug distributors have been under pressure by the speculated entry of Amazon into the prescription drug market.
"What (Amazon) will see is the magic isn't in lower net prices to consumers," Express Scripts CEO Tim Wentworth said. "It's getting the right drug to consumers and helping them navigate the system."
Mr. Wentworth was speaking to CNBC at the Forbes Healthcare Summit conference in New York. He made similar comments last month to analysts.
Last month, Express Scripts said it would "stand well" against any possible competition from Amazon in the pharmacy benefit management business, but added that the company would be a "natural collaborator" for the e-commerce giant.
PBMs negotiate drug benefits for health insurance plans and employers, and have in recent years taken an increasingly aggressive stance in price negotiations with drugmakers.
They often extract discounts and after-market rebates from drugmakers in exchange for including their medicines in PBM formularies with low co-payments.
In its annual study of drug costs, Express Scripts Holding Co. found that it lowered prescription drug spending for workers compensation payers by 7.6% in 2016, which accounts for a second-year decline in opioid prescribing, according to a report released Tuesday.